Induced Pluripotent Stem Cell-Derived Hematopoietic Embryoid Bodies Secrete Sphingosine-1-Phosphate and Revert...

Area of Science:

• Stem cell biology
• Immunology
• Biochemistry

Background:

• Sepsis is a life-threatening condition characterized by dysregulated host response to infection.
• Endothelial barrier dysfunction is a key pathological feature of sepsis.
• Sphingosine-1-phosphate is a bioactive lipid known to regulate endothelial barrier function.

Purpose of the Study:

• To investigate the production of sphingosine-1-phosphate by induced pluripotent stem cells (iPSCs).
• To evaluate the potential of iPSC-derived sphingosine-1-phosphate in mitigating sepsis-induced endothelial barrier damage.

Main Methods:

• Hematopoietic embryoid bodies were generated from differentiated 6-day-old iPSCs.
• Sphingosine-1-phosphate secretion by these embryoid bodies was measured.
• Effects on human umbilical vein endotheliocytes were assessed, focusing on barrier integrity and stress fiber formation.

Main Results:

• Induced pluripotent stem cell-derived embryoid bodies successfully secreted sphingosine-1-phosphate.
• Sphingosine-1-phosphate demonstrated protective effects on pulmonary endothelial barrier integrity.
• It prevented increased permeability and stress fiber formation in endotheliocytes.

Conclusions:

• Induced pluripotent stem cells are capable of producing functional sphingosine-1-phosphate.
• iPSC-derived sphingosine-1-phosphate holds therapeutic potential for sepsis treatment by preserving endothelial barrier function.